Story · Medicine & Biotech

Key immune driver of pancreatic cancer points to combination treatment for slowing progression

1 outlet · first reported by Medical Xpress on

Researchers from The University of Texas MD Anderson Cancer Center have discovered that the IL-18 inflammatory protein helps pancreatic tumors grow and evade the immune system, highlighting its potential as a therapeutic target for pancreatic cancer. (Medical Xpress)

Coverage, in order

  1. Key immune driver of pancreatic cancer points to combination treatment for slowing progression

    Researchers from The University of Texas MD Anderson Cancer Center have discovered that the IL-18 inflammatory protein helps pancreatic tumors grow and evade the immune system, highlighting its potential as a therapeutic target for pancreatic cancer.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.